Current Search Criteria:
Intervention: Venetoclax, Azacitidine, Cytarabine, Idarubicin, G-CSF
Found 8 matching trials
Venetoclax Plus CACAG Regimen for Newly Diagnosed Acute Myeloid Leukemia
PHASE2The purpose of this study is to compare the efficacy and safety of venetocl...
Location
Chinese PLA General Hospital
Venetoclax-Azacitidine in Combination With Chidamide and CAG in Fit Older Patients With Acute Myeloid Leukaemia
PHASE3This study is a multicenter, prospective, randomized, controlled clinical t...
Location
Chinese PLA General Hospital
IMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia.
PHASE3This is a multicenter, randomized, open-label, pragmatic low intervention c...
Location
University Hospital Brno
VA-CIG Regimen for Previously Untreated Acute Myeloid Leukemia: A Multicenter Prospective Single-Arm Trial
PHASE2This is a multicenter, prospective, single-arm clinical study designed to e...
Location
Chinese PLA General Hospital
Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage
PHASE3Phase III, multicenter, randomized study with two arms (1:1 ratio) enrollin...
Location
O'Neal Comprehensive Cancer Center
MRD Response-adapted Allo-HSCT for Adverse-risk AML
NAThis TROPHY-AML01 regimen aims to identify the effectiveness and safety of ...
Location
Peking University People's Hospital
A Multicenter RCT of "3+7" vs Venetoclax + CACAG in Newly Diagnosed Mid/High-Risk AML Patients
PHASE2The purpose of this study is to compare the efficacy and safety of venetocl...
Location
Chinese PLA General Hospital
Venetoclax Combined With CACAG Regimen Versus "3+7" Regimen in the Treatment of Acute Monocytic Leukemia
PHASE2This study is a multicenter, randomized, prospective Phase II clinical tria...
Location
Air Force Medical Center, PLA